HopeStage
Back to overview

Anxiety studies

Topics
More filters

Anxiety

Anxiety conditions involve intense, persistent fears or worries that can interfere with everyday life.

5111studies shown
Showing 805-816 of 5,111
Drug study icon
CompletedACTRN12609000091202

The use of tiagabine and gabapentin in the treatment of social anxiety disorder in 8 patients

Official study title

Gabapentin and tiagabine for treatment of social anxiety disorder in 8 patients in a random double blind crossover study with outcome measured as changes in the Leibowitz Social Anxiety Scale

This study has finished and is no longer accepting participants.

In United States
AnxietyInterventional studyAges 18–65
Countries
United States
Sponsor
Maria Urbano, M.D.
Drug study icon
Not recruitingISRCTN75061806

Agomelatine (25-50 mg/day) for anxiety

This study isn't currently recruiting.

In China
AnxietyResearch studyAges 18+
Countries
China, Malaysia, Singapore, + 2 others
Sponsor
Institut de Recherches Internationales Servier (France)
Drug study icon
Not recruitingISRCTN38094599

Agomelatine for anxiety

This study isn't currently recruiting.

In Canada
AnxietyResearch studyAges 18+
Countries
Canada, Denmark, Estonia, + 3 others
Sponsor
Institut de Recherches Internationales Servier (France)

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.